Konosuke Morimoto
Overview
Explore the profile of Konosuke Morimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1633
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maeda H, Morimoto K
Hum Vaccin Immunother
. 2025 Feb;
21(1):2469424.
PMID: 40015240
The introduction of pneumococcal conjugate vaccines (PCVs) into pediatric national immunization programs (NIP) has significantly reduced invasive pneumococcal diseases and pneumococcal pneumonia caused by PCV serotypes in adults due to...
2.
Ishimoto H, Sakamoto N, Yura H, Takazono T, Kido T, Matsumoto K, et al.
Respir Investig
. 2025 Jan;
63(1):180-182.
PMID: 39754899
Sargramostim, a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) inhalation therapy, was recently approved for pharmaceutical use in Japan and shows promise as a treatment for autoimmune pulmonary alveolar proteinosis (APAP)....
3.
Sasa N, Kojima S, Koide R, Hasegawa T, Namkoong H, Hirota T, et al.
Nat Genet
. 2025 Jan;
57(1):65-79.
PMID: 39753770
Aberrant immune responses to viral pathogens contribute to pathogenesis, but our understanding of pathological immune responses caused by viruses within the human virome, especially at a population scale, remains limited....
4.
Morimoto K, Masuda S
Respir Investig
. 2024 Dec;
63(1):96-101.
PMID: 39672073
Streptococcus pneumoniae, pneumococcus, is one of most important bacterial pathogens in adult community-acquired pneumonia. Although it can cause a variety of illness including invasive diseases (IPD), pneumonia has a greater...
5.
Maeda H, Saito N, Igarashi A, Ishida M, Terada M, Masuda S, et al.
Expert Rev Vaccines
. 2024 Jan;
23(1):213-225.
PMID: 38288980
Background: This study aimed to evaluate VE of primary, first, and second booster ancestral-strain monovalent mRNA COVID-19 vaccination against symptomatic infections and severe diseases in Japan. Methods: We conducted a...
6.
Dhoubhadel B, Sawada I, Shrestha D, Fukuya Y, Raya G, Nebie E, et al.
Trop Med Health
. 2024 Jan;
52(1):14.
PMID: 38281965
Background: A 7.8 R scale earthquake hit Nepal in April 2015 and caused about 9000 deaths along with damage to infrastructure, including the water and sewage system. Bhaktapur was one...
7.
Wakabayashi T, Hamaguchi S, Morimoto K
BMC Pulm Med
. 2023 Sep;
23(1):351.
PMID: 37718411
Background: Long-term hospital stay is associated with functional decline in patients with pneumonia, especially in the elderly. Among elderly patients with pneumonia, aspiration pneumonia is a major category. Clinical definition...
8.
Yamashita Y, Yasuda I, Tanaka T, Ikeda T, Terada M, Takaki M, et al.
Front Immunol
. 2023 Sep;
14:1275349.
PMID: 37691958
[This corrects the article DOI: 10.3389/fimmu.2023.1222428.].
9.
Yamashita Y, Yasuda I, Tanaka T, Ikeda T, Terada M, Takaki M, et al.
Front Immunol
. 2023 Jul;
14:1222428.
PMID: 37520555
Introduction: Controlling pulmonary complex (MAC) disease is difficult because there is no way to know the clinical stage accurately. There have been few attempts to use cell-mediated immunity for diagnosing...
10.
Maeda H, Saito N, Igarashi A, Ishida M, Terada M, Ito T, et al.
Expert Rev Vaccines
. 2023 Mar;
22(1):288-298.
PMID: 36883371
Background: Evaluating COVID-19 vaccine effectiveness (VE) domestically is crucial for assessing and determining national vaccination policy. This study aimed to evaluate VE of mRNA COVID-19 vaccines in Japan. Methods: We...